Allmed Medical Products Co.,Ltd (SHE:002950)
China flag China · Delayed Price · Currency is CNY
9.45
+0.01 (0.11%)
Sep 30, 2025, 3:04 PM CST

SHE:002950 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2017 - 2019
Operating Revenue
3,3863,2932,7074,1952,8883,796
Upgrade
Other Revenue
35.233.1249.415.7837.4438.58
Upgrade
3,4213,3262,7574,2112,9263,834
Upgrade
Revenue Growth (YoY)
17.50%20.66%-34.53%43.92%-23.70%63.00%
Upgrade
Cost of Revenue
2,4712,3982,0992,8122,0532,224
Upgrade
Gross Profit
950.46928.04657.931,399872.171,610
Upgrade
Selling, General & Admin
375.89374.65386.38446.53367.52286.51
Upgrade
Research & Development
126.39106.3777.37107.7494.58118.13
Upgrade
Other Operating Expenses
36.4710.4913.8226.4719.134.81
Upgrade
Operating Expenses
538.73494.41478.51582.45484.52410.9
Upgrade
Operating Income
411.72433.64179.42816.21387.651,200
Upgrade
Interest Expense
-18.61-25.53-31.87-35.47-17.18-17.66
Upgrade
Interest & Investment Income
7.517.161.873.0939.9750.58
Upgrade
Currency Exchange Gain (Loss)
23.0317.15-8.57-140.6333.4123.62
Upgrade
Other Non Operating Income (Expenses)
0.05-1.27-2-6.3-6.34-0.92
Upgrade
EBT Excluding Unusual Items
423.7431.15138.85636.9437.511,255
Upgrade
Gain (Loss) on Sale of Investments
-17.53-23.28-6.88-160.196.130.48
Upgrade
Gain (Loss) on Sale of Assets
29.3728.79-0.073.51.9426.34
Upgrade
Asset Writedown
-9.18-9.140.5-16.8-0.12-0.08
Upgrade
Other Unusual Items
44.8426.8736.6521.4959.7956.54
Upgrade
Pretax Income
470.27454.39169.04484.9505.491,339
Upgrade
Income Tax Expense
85.3785.5964.8380.2673.53178.2
Upgrade
Earnings From Continuing Operations
384.89368.8104.22404.64431.961,160
Upgrade
Minority Interest in Earnings
-3.37-0.126.182.15-0.75-2.94
Upgrade
Net Income
381.52368.68110.4406.79431.211,158
Upgrade
Net Income to Common
381.52368.68110.4406.79431.211,158
Upgrade
Net Income Growth
171.82%233.95%-72.86%-5.66%-62.75%255.27%
Upgrade
Shares Outstanding (Basic)
627625633633632633
Upgrade
Shares Outstanding (Diluted)
627625633633632633
Upgrade
Shares Change (YoY)
-0.76%-1.33%0.02%0.17%-0.05%2.81%
Upgrade
EPS (Basic)
0.610.590.170.640.681.83
Upgrade
EPS (Diluted)
0.610.590.170.640.681.83
Upgrade
EPS Growth
173.90%238.44%-72.87%-5.82%-62.73%245.58%
Upgrade
Free Cash Flow
587.4554.64137.02751.6884.161,193
Upgrade
Free Cash Flow Per Share
0.940.890.221.190.131.89
Upgrade
Dividend Per Share
0.0600.0600.0270.0600.2100.880
Upgrade
Dividend Growth
122.22%122.22%-55.00%-71.43%-76.14%120.00%
Upgrade
Gross Margin
27.78%27.90%23.87%33.22%29.81%42.00%
Upgrade
Operating Margin
12.04%13.04%6.51%19.38%13.25%31.28%
Upgrade
Profit Margin
11.15%11.08%4.00%9.66%14.74%30.19%
Upgrade
Free Cash Flow Margin
17.17%16.68%4.97%17.85%2.88%31.12%
Upgrade
EBITDA
644.2661.52403.431,008532.771,342
Upgrade
EBITDA Margin
18.83%19.89%14.64%23.95%18.21%34.99%
Upgrade
D&A For EBITDA
232.47227.88224192.2145.12142.22
Upgrade
EBIT
411.72433.64179.42816.21387.651,200
Upgrade
EBIT Margin
12.04%13.04%6.51%19.38%13.25%31.28%
Upgrade
Effective Tax Rate
18.15%18.84%38.35%16.55%14.55%13.31%
Upgrade
Revenue as Reported
3,4213,3262,7574,2112,9263,834
Upgrade
Advertising Expenses
-17.9715.98-27.18.91
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.